Your browser doesn't support javascript.
loading
The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer.
Liu, Yiqiang; Wu, Hong; Luo, Tao; Luo, Qiyu; Meng, Ziyu; Shi, Ying; Li, Feifei; Liu, Mingxin; Peng, Xinhao; Liu, Junjie; Xu, Chuan; Tang, Weizhong.
Afiliação
  • Liu Y; Department of Experimental Research, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Wu H; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Luo T; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Luo Q; Department of Experimental Research, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Meng Z; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Shi Y; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Li F; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Liu M; Department of Experimental Research, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Peng X; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Liu J; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Xu C; Integrative Cancer Center and Cancer Clinical Research Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Tang W; Department of Experimental Research, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Front Mol Biosci ; 8: 646542, 2021.
Article em En | MEDLINE | ID: mdl-34124145
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Mol Biosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Mol Biosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China